Lumida
/KYMR
⌘K
Kymera Therapeutics Inc

Kymera Therapeutics Inc

KYMR
$115.77USD+1.56%+1.78 today

MARKET CAP

9.5B

P/E (TTM)

FWD P/E

DAY RANGE

$110 – $117

52W RANGE

$37
$130

AI Summary

Stalk
Buy NowMedium

KYMR remains in a Stage 2 advancing uptrend with higher highs and lows intact. Price has pulled back into the rising 9/21 EMA zone and is holding above key support, offering a favorable entry. Although RSI and Options Score are overbought and a Bullish Exhaustion signal warns of potential pullback, the advancing regime, rising moving averages, and RS outperformance support a bullish bias. Execution on this pullback into dynamic EMA support is preferred, while monitoring for distribution risk at the June swing low.

  • 97% stock gain over past year signals high momentum factor.
  • Phase 2b KT-621 enrollment completed early; topline data due by end-2026.
  • R&D spend of $98.2M in Q1 strains resources amid development risk.
Full analysis →
Insider Trades54 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 7, 2026SellKYMRNello MainolfiChief Executive Officer100,000$60.54$9.5B-10.98%+215.88%$6.1M+0.00%10b5-1Buy Now
Jul 1, 2026SellKYMRNoah GoodmanChief Business Officer3,389$114.29$9.5B-10.98%+215.88%$387.3K-6.70%10b5-1Buy Now
Jul 1, 2026SellKYMRNello MainolfiChief Executive Officer160,000$58.69$9.5B-10.98%+215.88%$9.4M+0.00%10b5-1Buy Now
Jun 30, 2026SellKYMRBruce N. JacobsChief Financial Officer138,487$66.37$9.5B-10.98%+215.88%$9.2M-0.60%10b5-1Buy Now
Jun 25, 2026SellKYMRNoah GoodmanChief Business Officer10,000$67.53$9.5B-10.98%+215.88%$675.3K+0.00%10b5-1Buy Now
Jun 22, 2026SellKYMRNoah GoodmanChief Business Officer5,000$60.02$9.5B-10.98%+215.88%$300.1K+0.00%10b5-1Buy Now
Jun 2, 2026BuyKYMRBruce N. JacobsChief Financial Officer12,653$2.08$9.5B-10.98%+215.88%$26.3K+5.11%Buy Now
May 26, 2026SellKYMRJeremy G ChadwickChief Operating Officer17,184$79.92$9.5B-10.98%+215.88%$1.4M-4.63%10b5-1Buy Now
May 18, 2026BuyKYMRBruce N. JacobsChief Financial Officer15,000$2.08$9.5B-10.98%+215.88%$31.2K+6.12%Buy Now
Apr 29, 2026SellKYMRNello MainolfiChief Executive Officer60,000$41.63$9.5B-10.98%+215.88%$2.5M+0.00%10b5-1Buy Now
Apr 22, 2026SellKYMRJeremy G ChadwickChief Operating Officer600$64.53$9.5B-10.98%+215.88%$38.7K+0.00%10b5-1Buy Now
Apr 14, 2026SellKYMRNoah GoodmanChief Business Officer1,347$90.00$9.5B-10.98%+215.88%$121.2K-2.61%10b5-1Buy Now
Apr 14, 2026SellKYMRJeremy G ChadwickChief Operating Officer13,102$62.21$9.5B-10.98%+215.88%$815.0K+0.00%10b5-1Buy Now
Apr 9, 2026SellKYMRNoah GoodmanChief Business Officer12,764$74.46$9.5B-10.98%+215.88%$950.4K-2.01%10b5-1Buy Now
Mar 31, 2026SellKYMRJeremy G ChadwickChief Operating Officer44,480$57.54$9.5B-10.98%+215.88%$2.6M+0.00%10b5-1Buy Now
Mar 23, 2026SellKYMRJeremy G ChadwickChief Operating Officer225,104$54.57$9.5B-10.98%+215.88%$12.3M-0.75%10b5-1Buy Now
Mar 11, 2026SellKYMRJeremy G ChadwickChief Operating Officer45,758$65.90$9.5B-10.98%+215.88%$3.0M-1.44%10b5-1Buy Now
Mar 2, 2026SellKYMRJeremy G ChadwickChief Operating Officer5,958$86.54$9.5B-10.98%+215.88%$515.6K-1.05%Buy Now
Mar 2, 2026SellKYMRJared GollobChief Medical Officer10,508$87.24$9.5B-10.98%+215.88%$916.7K-1.17%Buy Now
Mar 2, 2026SellKYMRBruce N. JacobsChief Financial Officer12,471$87.50$9.5B-10.98%+215.88%$1.1M-0.73%Buy Now
Feb 25, 2026SellKYMRNello MainolfiChief Executive Officer60,000$46.17$9.5B-10.98%+215.88%$2.8M+0.00%10b5-1Buy Now
Jan 5, 2026BuyKYMRNello MainolfiChief Executive Officer3,118$32.07$9.5B-10.98%+215.88%$100.0K+0.28%Buy Now
Dec 31, 2025SellKYMRNello MainolfiChief Executive Officer60,000$40.07$9.5B-10.98%+215.88%$2.4M+0.00%10b5-1Buy Now
Dec 17, 2025BuyKYMRNello MainolfiChief Executive Officer2,595$38.53$9.5B-10.98%+215.88%$100.0K+0.28%Buy Now
Dec 8, 2025SellKYMRJared GollobChief Medical Officer98,614$47.00$9.5B-10.98%+215.88%$4.6M+0.00%10b5-1Buy Now
Dec 8, 2025SellKYMRNello MainolfiChief Executive Officer200,000$45.63$9.5B-10.98%+215.88%$9.1M+0.00%10b5-1Buy Now
Oct 29, 2025SellKYMRNello MainolfiChief Executive Officer60,000$31.54$9.5B-10.98%+215.88%$1.9M+0.00%10b5-1Buy Now
Oct 15, 2025SellKYMRJared GollobChief Medical Officer110,785$33.79$9.5B-10.98%+215.88%$3.7M-1.02%10b5-1Buy Now
Oct 13, 2025SellKYMRJared GollobChief Medical Officer4,587$41.27$9.5B-10.98%+215.88%$189.3K-0.40%10b5-1Buy Now
Sep 17, 2025SellKYMRBruce N. JacobsChief Financial Officer158,440$26.04$9.5B-10.98%+215.88%$4.1M+0.00%10b5-1Buy Now
Sep 16, 2025SellKYMRNello MainolfiChief Executive Officer60,000$25.54$9.5B-10.98%+215.88%$1.5M+0.00%10b5-1Buy Now
Jun 3, 2025SellKYMRNello MainolfiChief Executive Officer60,000$25.54$9.5B-10.98%+215.88%$1.5M+0.00%10b5-1Buy Now
May 23, 2025SellKYMRJeremy G ChadwickChief Operating Officer2,575$29.30$9.5B-10.98%+215.88%$75.4K-3.73%Buy Now
Mar 31, 2025BuyKYMRBruce N. JacobsChief Financial Officer25,000$2.08$9.5B-10.98%+215.88%$52.0K+9.20%Buy Now
Mar 3, 2025SellKYMRJeremy G ChadwickChief Operating Officer1,383$30.45$9.5B-10.98%+215.88%$42.1K-0.74%Buy Now
Mar 3, 2025SellKYMREllen ChiniaraChief Legal Officer2,241$30.45$9.5B-10.98%+215.88%$68.2K-1.03%Buy Now
Mar 3, 2025SellKYMRJared GollobChief Medical Officer5,740$30.45$9.5B-10.98%+215.88%$174.8K-1.87%Buy Now
Mar 3, 2025SellKYMRBruce N. JacobsChief Financial Officer7,035$30.45$9.5B-10.98%+215.88%$214.2K-1.49%Buy Now
Jan 10, 2025BuyKYMRBruce N. JacobsChief Financial Officer10,000$2.08$9.5B-10.98%+215.88%$20.8K+3.79%Buy Now
Jan 10, 2025BuyKYMRNello MainolfiChief Executive Officer10,000$2.08$9.5B-10.98%+215.88%$20.8K+0.87%Buy Now
Jan 6, 2025SellKYMREllen ChiniaraChief Legal Officer3,129$41.75$9.5B-10.98%+215.88%$130.6K-5.40%Buy Now
Jul 15, 2024SellKYMRJared GollobChief Medical Officer79,200$23.81$9.5B-10.98%+215.88%$1.9M+0.00%10b5-1Buy Now
Jul 1, 2024BuyKYMRNello MainolfiChief Executive Officer18,773$5.33$9.5B-10.98%+215.88%$100.1K+2.04%Buy Now
Jun 27, 2024BuyKYMRBruce N. JacobsChief Financial Officer25,000$2.08$9.5B-10.98%+215.88%$52.0K+10.06%Buy Now
Jun 18, 2024BuyKYMRNello MainolfiChief Executive Officer14,413$2.08$9.5B-10.98%+215.88%$30.0K+1.28%Buy Now
May 23, 2024SellKYMRJeremy G ChadwickChief Operating Officer2,575$34.99$9.5B-10.98%+215.88%$90.1K-5.51%Buy Now
Mar 4, 2024SellKYMRJared GollobChief Medical Officer3,344$41.86$9.5B-10.98%+215.88%$140.0K-0.76%Buy Now
Mar 4, 2024SellKYMRBruce N. JacobsChief Financial Officer3,934$41.86$9.5B-10.98%+215.88%$164.7K-0.63%Buy Now
Feb 27, 2024SellKYMRJared GollobChief Medical Officer800$23.54$9.5B-10.98%+215.88%$18.8K+0.00%10b5-1Buy Now
Feb 9, 2024SellKYMRJared GollobChief Medical Officer92,274$18.79$9.5B-10.98%+215.88%$1.7M+0.00%10b5-1Buy Now
Jan 4, 2024SellKYMREllen ChiniaraChief Legal Officer3,295$22.58$9.5B-10.98%+215.88%$74.4K-8.79%Buy Now
Jan 2, 2024BuyKYMRNello MainolfiChief Executive Officer9,000$2.08$9.5B-10.98%+215.88%$18.7K+0.80%Buy Now
Nov 3, 2023BuyKYMRNello MainolfiChief Executive Officer20,000$2.08$9.5B-10.98%+215.88%$41.6K+1.17%Buy Now
Aug 8, 2023BuyKYMRNello MainolfiChief Executive Officer12,000$2.08$9.5B-10.98%+215.88%$25.0K+2.08%Buy Now